S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73%
Market Cap: 20.1m EUR

Surgalign Holdings Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Surgalign Holdings Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgalign Holdings Inc
F:RT2
Cash & Cash Equivalents
$22.4m
CAGR 3-Years
50%
CAGR 5-Years
10%
CAGR 10-Years
-5%
Haemonetics Corp
NYSE:HAE
Cash & Cash Equivalents
$296.4m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
11%
ICU Medical Inc
NASDAQ:ICUI
Cash & Cash Equivalents
$299.7m
CAGR 3-Years
7%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Align Technology Inc
NASDAQ:ALGN
Cash & Cash Equivalents
$190.8m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
1%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash & Cash Equivalents
$382m
CAGR 3-Years
14%
CAGR 5-Years
34%
CAGR 10-Years
33%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash & Cash Equivalents
$392.5m
CAGR 3-Years
97%
CAGR 5-Years
54%
CAGR 10-Years
52%
No Stocks Found

Surgalign Holdings Inc
Glance View

Market Cap
20.1m EUR
Industry
Health Care

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.

RT2 Intrinsic Value
Not Available
S

See Also

What is Surgalign Holdings Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
22.4m USD

Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Cash & Cash Equivalents amounts to 22.4m USD.

What is Surgalign Holdings Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-5%

Over the last year, the Cash & Cash Equivalents growth was -50%. The average annual Cash & Cash Equivalents growth rates for Surgalign Holdings Inc have been 50% over the past three years , 10% over the past five years , and -5% over the past ten years .

Back to Top